Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,14119,160 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2023

PROJECT SUMMARY: Glioblastoma (GBM) is the most common primary malignant brain tumor, with a median survival of up to 20 months. Males have a 1.6-fold higher incidence of GBM compa...

$1.2M
USD
Completed NON-SBIR/STTR RPGS
The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2026

Project Summary Childhood cancer survivors treated with abdominal or pelvic radiotherapy (RT) are almost four times more likely to develop colorectal cancer (CRC) compared to the g...

$6.52M
USD
Completed NON-SBIR/STTR RPGS
A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2026

Abstract/Summary Chemotherapy and radiation can induce breast tumors to enter a prolonged state of growth arrest with characteristics of senescence. A senescent-like state is also...

$4.99M
USD
Completed NON-SBIR/STTR RPGS
Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2024

Project Summary Advances in human genetics have identified +400 genes that when amplified or mutated promote tumorigenesis. While there has been huge success in developing drugs fo...

$1.92M
USD
Completed NON-SBIR/STTR RPGS
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
NATIONAL CANCER INSTITUTE Endeavor Health Clinical Operations United States 2021 – 2026

PROJECT SUMMARY The development of novel therapies for the treatment of breast cancer is a major unmet need. In recent years, immune checkpoint inhibitors including anti-PD-1, anti...

$3.74M
USD
Completed OTHER RESEARCH-RELATED
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2023

Abstract: The Hippo pathway is an evolutionarily conserved signaling cascade regulating numerous biological processes, including cell growth and fate decision, organ size control,...

$1.7M
USD
Completed NON-SBIR/STTR RPGS
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2021 – 2026

Project Summary The overarching goal of this project is to develop a tumor organoid-based drug screening platform that quantifies the differential drug responsiveness of tumor clon...

$4.95M
USD
Completed NON-SBIR/STTR RPGS
Longitudinal investigation of sociocultural and behavioral influences on symptom management, biological response, and functioning between Chinese and White breast cancer survivors.
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

PROJECT SUMMARY The number of US cancer survivors is growing rapidly, including a significant number of Chinese Americans (CA), a group with an annual breast cancer growth rate of...

$6.29M
USD
Completed NON-SBIR/STTR RPGS
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Radiation plays a central role in the management of the most lethal central nervous system malignancy, glioblastoma (GBM), yet local control rates, and hen...

$4.61M
USD
Completed NON-SBIR/STTR RPGS
TURNing RanBP9 on NSCLC
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2023

Project Summary Remarkable advancements have been recently achieved in the treatment of Non-Small Cell Lung Cancer (NSCLC). Targeted- and immune-therapy have produced spectacular p...

$764.4K
USD
Completed NON-SBIR/STTR RPGS
Modeling Esophageal Squamous Cell Cancer Initiation
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Esophageal squamous cell carcinoma (ESCC) accounts for over 80% of all cases of esophageal cancer and has a poor prognosis because of a lack of symptoms at...

$810K
USD
Completed NON-SBIR/STTR RPGS
Technology Facilitated Behavioral Intervention for Depression among Diverse Patients in Ambulatory Oncology
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

AbstractDepressionis one of the most common psychological comorbidities experienced throughout the cancercontinuum. Elevated depressive symptoms in oncology patients is a major con...

$6.49M
USD
Completed NON-SBIR/STTR RPGS
Image-based models of tumor-immune dynamics in glioblastoma
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2021 – 2026

ABSTRACT The use of immunotherapy to treat cancer continues to generate hope and excitement among those involved in cancer care and research. However, our inability to explain why...

$8.15M
USD
Completed NON-SBIR/STTR RPGS
Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2026

The goal of this proposal is to define the role of each component of the ARTN/GFR3/TRPM8 signaling pathway in radiation-associated pain (RAP). A common consequence of radiotherapy...

$3.48M
USD
Completed NON-SBIR/STTR RPGS
Social Health, Activity Behaviors, and Quality of Life among Young Adult Cancer Survivors: A Longitudinal Study
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2026

Abstract Approximately 70,000 adolescents and young adults are diagnosed with cancer between the ages of 15-39 in the U.S. every year. Due to their age and life stage, the experien...

$6.66M
USD
Completed NON-SBIR/STTR RPGS
Reposition and Optimization of Deferiprone for Breast Cancer Therapy
NATIONAL CANCER INSTITUTE Georgia Institute of Technology United States 2021 – 2026

Project Summary/Abstract: In 2020 there will be ~ 276,480 estimated new cases of invasive breast cancer (BCa) among women in the US, causing an estimated ~ 42,170 deaths. Two commo...

$4.37M
USD
Active NON-SBIR/STTR RPGS
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY Most children treated for cancer in the US will achieve long-term survival, and survivorship presents unique challenges for this growing population. Pediatric brain...

$12.43M
USD
Completed NON-SBIR/STTR RPGS
Novel 7SK non-coding RNA fusions in soft tissue sarcomas to tumorigenesis
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2023

PROJECT SUMMARY Soft tissue sarcomas (STS) are rare tumors of mesenchymal origin that are often characterized by diagnostic fusion oncoproteins corresponding with tumor subtype. We...

$841K
USD
Completed NON-SBIR/STTR RPGS
Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

Despite advances in our understanding of the genetic origins of AML, treatment options have remained essentially unchanged for 30-years, and clinical outcomes remain poor. Leukemia...

$5.89M
USD
Completed NON-SBIR/STTR RPGS
Small molecule probes of MYC stability and function intumorigenesis
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

ABSTRACT MYC oncoproteins (including c-MYC, L-MYC and N-MYC) play critical roles in the initiation, progression and recurrence of many human malignancies. Extensive studies indicat...

$5.6M
USD